Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.89-0.29 (-4.69%)
At close: 4:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 358.37
52 Week Low 35.59
50-Day Moving Average 36.72
200-Day Moving Average 313.02

Share Statistics

Avg Vol (3 month) 3170.38k
Avg Vol (10 day) 3165.69k
Shares Outstanding 534.22M
Implied Shares Outstanding 6N/A
Float 832.65M
% Held by Insiders 17.86%
% Held by Institutions 157.84%
Shares Short (Oct 14, 2021) 44.59M
Short Ratio (Oct 14, 2021) 423.36
Short % of Float (Oct 14, 2021) 418.55%
Short % of Shares Outstanding (Oct 14, 2021) 413.33%
Shares Short (prior month Sep 14, 2021) 45.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin -152.00%
Operating Margin (ttm)-151.36%

Management Effectiveness

Return on Assets (ttm)-15.70%
Return on Equity (ttm)-32.71%

Income Statement

Revenue (ttm)35.27M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)10.50%
Gross Profit (ttm)4.96M
EBITDA -51.39M
Net Income Avi to Common (ttm)-53.6M
Diluted EPS (ttm)-10.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)168.89M
Total Cash Per Share (mrq)4.91
Total Debt (mrq)46.37M
Total Debt/Equity (mrq)27.93
Current Ratio (mrq)19.09
Book Value Per Share (mrq)-25.04

Cash Flow Statement

Operating Cash Flow (ttm)-68.71M
Levered Free Cash Flow (ttm)-57.23M
Advertisement
Advertisement